X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6632) 6632
Book Review (722) 722
Publication (506) 506
Book / eBook (17) 17
Newsletter (16) 16
Magazine Article (14) 14
Book Chapter (10) 10
Conference Proceeding (6) 6
Government Document (5) 5
Newspaper Article (5) 5
Dissertation (3) 3
Data Set (2) 2
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (6040) 6040
humans (4643) 4643
male (3547) 3547
pneumonia - chemically induced (2806) 2806
female (2703) 2703
animals (2415) 2415
middle aged (1593) 1593
pneumonia (1525) 1525
adult (1470) 1470
mice (1297) 1297
aged (1266) 1266
respiratory system (1024) 1024
abridged index medicus (1004) 1004
pneumonia - pathology (922) 922
inflammation (919) 919
lung - pathology (889) 889
lung - drug effects (760) 760
bacterial pneumonia (687) 687
rats (647) 647
pneumonia - drug therapy (629) 629
pharmacology & pharmacy (628) 628
pneumonia - metabolism (620) 620
disease models, animal (579) 579
risk factors (579) 579
immunology (517) 517
pneumonia - immunology (517) 517
toxicology (513) 513
mice, inbred c57bl (502) 502
lung (490) 490
lung - metabolism (474) 474
time factors (455) 455
medicine, general & internal (453) 453
research (442) 442
bronchoalveolar lavage fluid - cytology (413) 413
health aspects (406) 406
treatment outcome (403) 403
analysis (399) 399
lungs (381) 381
therapy (369) 369
adolescent (362) 362
oncology (357) 357
dose-response relationship, drug (356) 356
toxicity (352) 352
aged, 80 and over (338) 338
tomography, x-ray computed (334) 334
acute disease (327) 327
care and treatment (325) 325
disease (323) 323
retrospective studies (322) 322
expression (321) 321
anti-bacterial agents - adverse effects (317) 317
asthma (316) 316
rodents (316) 316
bronchoalveolar lavage fluid - chemistry (308) 308
mice, inbred balb c (306) 306
lung - immunology (290) 290
pneumonia, aspiration - chemically induced (287) 287
infectious diseases (286) 286
pulmonary fibrosis - chemically induced (284) 284
radiography (275) 275
cytokines (271) 271
administration, inhalation (269) 269
mortality (267) 267
respiratory tract diseases (266) 266
lung diseases (261) 261
child (260) 260
antineoplastic agents - adverse effects (259) 259
cell biology (256) 256
anti-bacterial agents - therapeutic use (254) 254
oxidative stress (253) 253
pneumonia - diagnosis (253) 253
pneumonia, pneumocystis - drug therapy (250) 250
proteins (249) 249
lung diseases, interstitial - chemically induced (248) 248
microbiology (248) 248
cells (246) 246
article (245) 245
pneumonia - prevention & control (244) 244
mice, knockout (239) 239
biochemistry & molecular biology (238) 238
lung diseases - chemically induced (237) 237
rats, sprague-dawley (237) 237
infections (236) 236
pneumonia - physiopathology (233) 233
diagnosis, differential (230) 230
exposure (229) 229
drug therapy (228) 228
physiology (228) 228
research article (226) 226
medicine (225) 225
cancer (224) 224
child, preschool (223) 223
infection (222) 222
macrophages (222) 222
medicine & public health (222) 222
infant (217) 217
hematology (216) 216
pneumonia - diagnostic imaging (214) 214
cytokines - metabolism (213) 213
inhalation (210) 210
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5931) 5931
Japanese (172) 172
German (143) 143
French (120) 120
Spanish (93) 93
Russian (80) 80
Chinese (35) 35
Dutch (22) 22
Polish (22) 22
Italian (15) 15
Danish (11) 11
Hebrew (10) 10
Portuguese (7) 7
Swedish (7) 7
Hungarian (6) 6
Finnish (5) 5
Norwegian (5) 5
Croatian (4) 4
Czech (3) 3
Romanian (2) 2
Serbian (2) 2
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Physiology - Lung Cellular and Molecular Physiology, ISSN 1040-0605, 07/2014, Volume 307, Issue 2, pp. L158 - L172
Journal Article
Blood, ISSN 0006-4971, 04/2015, Volume 125, Issue 16, pp. 2497 - 2506
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 1, pp. 27 - 38
Journal Article
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 5, pp. 599 - 610
Journal Article
American Journal of Respiratory and Critical Care Medicine, ISSN 1073-449X, 03/2010, Volume 181, Issue 6, pp. 604 - 610
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 5, pp. 640 - 653
Summary Background Although trastuzumab plus chemotherapy is the standard of care for first-line treatment of HER2-positive advanced gastric cancer, there is... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | SUPPORTIVE CARE | WEEKLY PACLITAXEL | ONCOLOGY | 2ND-LINE CHEMOTHERAPY | IRINOTECAN | LEVEL | PLUS PACLITAXEL | HER2 | CANCER | DOCETAXEL | Follow-Up Studies | Febrile Neutropenia - chemically induced | Humans | Middle Aged | Male | Stomach Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Taxoids - therapeutic use | Antineoplastic Agents - adverse effects | Pneumonia - chemically induced | Aged, 80 and over | Adult | Female | Stomach Neoplasms - chemistry | Adenocarcinoma - chemistry | Taxoids - adverse effects | Antibodies, Monoclonal, Humanized - adverse effects | Maytansine - adverse effects | Bridged-Ring Compounds - therapeutic use | Antibodies, Monoclonal, Humanized - therapeutic use | Maytansine - analogs & derivatives | Anemia - chemically induced | Survival Rate | Thrombocytopenia - chemically induced | Stomach Neoplasms - drug therapy | Maytansine - therapeutic use | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Esophagogastric Junction | Gastrointestinal Hemorrhage - chemically induced | Retreatment | Intention to Treat Analysis | Bridged-Ring Compounds - adverse effects | Aged | Receptor, ErbB-2 - analysis | Trastuzumab | Adenocarcinoma | Medical research | Chemotherapy | Clinical trials | Medicine, Experimental | Metastasis | Esophageal cancer | Cancer | Analysis | Index Medicus
Journal Article
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, ISSN 0022-3565, 05/2014, Volume 349, Issue 2, pp. 209 - 220
Journal Article
Oncology (Williston Park, N.Y.), ISSN 0890-9091, 07/2018, Volume 32, Issue 7, pp. 339 - 343
Poly(ADP-ribose) polymerase (PARP) proteins are used by cells in several DNA repair processes. PARP inhibition can result in preferential death of cancer cells... 
MULTICENTER | ONCOLOGY | RECURRENT | SAFETY | MUTATION CARRIERS | POLYMERASE INHIBITOR | PHASE-3 TRIAL | DOUBLE-BLIND | OPEN-LABEL | OLAPARIB MAINTENANCE THERAPY | CHEMOTHERAPY | Nasopharyngitis - prevention & control | Nausea - chemically induced | Humans | Nasopharyngitis - chemically induced | Anemia - prevention & control | Fatigue - chemically induced | Ovarian Neoplasms - genetics | Heart Rate - drug effects | Drug Interactions | Exanthema - chemically induced | Pneumonia - chemically induced | Hypertension - chemically induced | Myelodysplastic Syndromes - chemically induced | Leukopenia - chemically induced | Genes, BRCA2 | Hypertension - prevention & control | Exanthema - prevention & control | Female | Genes, BRCA1 | Ovarian Neoplasms - drug therapy | Vomiting - prevention & control | Leukopenia - prevention & control | Fatigue - prevention & control | Drug Administration Schedule | Anemia - chemically induced | Thrombocytopenia - chemically induced | Poly(ADP-ribose) Polymerase Inhibitors - therapeutic use | Nausea - prevention & control | Poly(ADP-ribose) Polymerase Inhibitors - economics | Vomiting - chemically induced | Piperidines - therapeutic use | Creatinine - blood | Thrombocytopenia - prevention & control | Transaminases - blood | Mutation | Indazoles - therapeutic use | Chemotherapy | Development and progression | Drug therapy | Health aspects | Drug approval | Ovarian cancer | Cancer | Index Medicus
Journal Article
Rheumatology (United Kingdom), ISSN 1462-0324, 03/2017, Volume 56, Issue 3, pp. 378 - 383
Objective. The main aim of this study was to examine the differences between triple therapy (T: SSZ and HCQ added to MTX) and etanercept (E) added to MTX with... 
Clinical trials and methods | Infection and arthritis | DMARDs | Rheumatoid arthritis | Biological therapies | biological therapies | MODIFYING ANTIRHEUMATIC DRUGS | TUBERCULOSIS | METHOTREXATE | RISK | RHEUMATOLOGY | rheumatoid arthritis | clinical trials and methods | TRIAL | infection and arthritis | RECOMMENDATIONS | SERIOUS BACTERIAL-INFECTIONS | FACTOR-ALPHA ANTAGONISTS | AGENTS | Intestinal Obstruction - epidemiology | Gastrointestinal Diseases - epidemiology | Humans | Middle Aged | Abscess - epidemiology | Male | Hydroxychloroquine - adverse effects | Intestinal Obstruction - chemically induced | Abscess - chemically induced | Infection - chemically induced | Incidence | Infection - epidemiology | Urinary Tract Infections - chemically induced | Arthritis, Rheumatoid - drug therapy | Pneumonia - chemically induced | Antirheumatic Agents - adverse effects | Respiratory Tract Infections - chemically induced | Adult | Female | Drug Therapy, Combination | Etanercept - adverse effects | Ileus - chemically induced | Pancreatitis - epidemiology | Pneumonia - epidemiology | Linear Models | Pancreatitis - chemically induced | Gastritis - epidemiology | Methotrexate - adverse effects | Urinary Tract Infections - epidemiology | Gastritis - chemically induced | Aged | Respiratory Tract Infections - epidemiology | Sulfasalazine - adverse effects | Gastrointestinal Diseases - chemically induced | Ileus - epidemiology | Index Medicus | Abridged Index Medicus | Clinical Science | 53
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 04/2015, Volume 74, Issue 4, pp. 675 - 681
Objectives Data concerning rates of gastrointestinal (GI) events in non-steroidal anti-inflammatory drug (NSAID) users derive mainly from clinical trials. The... 
ULCERS | ESOMEPRAZOLE | REQUIRE NSAIDS | DOUBLE-BLIND | PREVENTION |